Showing results (561-570 of 862) with videos related to

Sort By:
Pageof 87
Brachytherapy|February 9, 2017
Intraoperative high-dose-rate brachytherapy: An American Brachytherapy Society consensus reportS Lloyd, K M Alektiar, S Nag, et al.
Molecular and Cellular Endocrinology|August 1, 1982
The specificity of inhibin bioassay using cultured pituitary cellsR S Scott, H G Burger, H Quigg, et al.
Diabetes Care|February 28, 2004
Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care settingSarah J Beaton, Soma S Nag, Margaret J Gunter, et al.
Bioorganic & Medicinal Chemistry|December 6, 2012
Synthesis and biological evaluation of novel propargyl amines as potential fluorine-18 labeled radioligands for detection of MAO-B activityS Nag, G Kettschau, T Heinrich, et al.
Clinical Chemistry|May 1, 1999
Combined inhibin and CA125 assays in the detection of ovarian cancerD M Robertson, N Cahir, H G Burger, et al.
Clinical Endocrinology|April 1, 1996
Characterization of inhibin immunoreactivity in post-menopausal women with ovarian tumoursH G Burger, D M Robertson, N Cahir, et al.
Endocrinology|November 1, 1988
Pregnant mare's serum gonadotropin stimulates inhibin subunit gene expression in the immature rat ovary: dose response characteristics and relationships to serum gonadotropins, inhibin, and ovarian steroid contentS R Davis, H G Burger, D M Robertson, et al.
Clinical Endocrinology|August 26, 1998
Serum inhibins A and B fall differentially as FSH rises in perimenopausal womenH G Burger, N Cahir, D M Robertson, et al.
Mymensingh Medical Journal : MMJ|October 1, 2023
Hypoalbuminaemia as a Marker of Severity of Patients of Community Acquired PneumoniaD Biswas, S Nag, A U Khan, et al.
Cytotechnology|February 24, 2012
Biological activity and metabolic clearance of recombinant human follicle stimulating hormone produced in Sp2/0 myeloma cellsC K Chin, P R Schofield, D M Robertson, et al.
Pageof 87